Tscan Therapeutics Inc
(TCRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -61,803 | -30,142 | -89,218 | -69,605 | -46,608 |
| Depreciation Amortization | 2,370 | 1,254 | 5,361 | 4,081 | 2,795 |
| Accounts receivable | N/A | N/A | N/A | N/A | -31,926 |
| Accounts payable and accrued liabilities | -14 | -410 | -52 | 589 | 862 |
| Other Working Capital | 74 | -2,109 | 17,606 | 23,804 | -4,595 |
| Other Operating Activity | 3,881 | 2,140 | 4,945 | 3,539 | 33,863 |
| Operating Cash Flow | $-55,492 | $-29,267 | $-61,358 | $-37,592 | $-45,609 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,567 | -705 | -3,146 | -2,677 | -1,258 |
| Purchase Of Investment | -57,133 | -8,779 | -77,613 | -59,995 | N/A |
| Sale Of Investment | 61,147 | 45,647 | 20,000 | N/A | N/A |
| Investing Cash Flow | $2,447 | $36,163 | $-60,759 | $-62,672 | $-1,258 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 161,845 | 258 | 135,443 | 135,424 | 135,676 |
| Financing Cash Flow | $161,845 | $258 | $135,443 | $135,424 | $135,676 |
| Beginning Cash Position | 138,390 | 138,390 | 125,064 | 125,064 | 125,064 |
| End Cash Position | 247,190 | 145,544 | 138,390 | 160,224 | 213,873 |
| Net Cash Flow | $108,800 | $7,154 | $13,326 | $35,160 | $88,809 |
| Free Cash Flow | |||||
| Operating Cash Flow | -55,492 | -29,267 | -61,358 | -37,592 | -45,609 |
| Capital Expenditure | -1,567 | -705 | -3,146 | -2,677 | -1,258 |
| Free Cash Flow | -57,059 | -29,972 | -64,504 | -40,269 | -46,867 |